Materialise Dental will appeal the ruling of the Central District Court of California in its patent litigation case against Nobel Biocare

Summary:

The Central District Court in Santa Ana, California, has ruled in favor of Nobel Biocare in the ongoing lawsuit between Materialise and Nobel.

Full Article:

The Central District Court in Santa Ana, California, has ruled that Nobel Biocare's NobelGuide system does not infringe claim 1 of Materialise's '134 patent.

This verdict is only one element in the ongoing litigation between both companies. As Materialise Dental
believes this decision is in error and remains confident of its patent position, it will appeal this
decision to the U.S. Federal Circuit Court.

"While we can’t understand this unfavorable ruling, we remain confident that NobelGuide infringes our patents, and that the court of appeal will confirm this." says Bart Swaelens, CEO of Materialise Dental, a world leader in computer guided implantology.

Materialise filed a patent infringement action against Nobel Biocare in Düsseldorf, Germany in July 2006.
Materialise alleges that Nobel Biocare’s NobelGuide solution infringes Materialise’s European patent, (EP) 0 756 735, which is exclusively licensed to Materialise
Dental.

On 17 March 2009, the Central District Court of California issued an order granting Nobel Biocare’s motion for summary judgment of non-infringement. As Materialise believes this decision is in error and remains confident of its patent position, it will appeal this decision to the U.S. Federal Circuit Court.

About Materialise Dental:
Materialise Dental focuses on 3D Digital Dentistry, by offering a range of products and services to support dental specialists in the treatment of their patients.
Materialise Dental continues to lead the dental industry in medical image processing, surgery simulation and rapid prototyping technology.

Source:

Materialise Dental